Interventional period (n = 34) | Control period (n = 14) | p value | |
---|---|---|---|
Pre-analytical TAT | |||
From admission to screening (h) | 11.6 (IQR 2.0–21.8) | 6.2 (IQR 3.2–33.3) | 0.759 |
Analytical TAT | |||
From screening to arrival in the laboratory (h) | 2.5 (IQR 1.5–11.3) | 6.4 (IQR 2.3–19.0) | 0.189 |
From receipt to result notification (h)a | 2.6 (IQR 2.1–28.8) | 40.4 (IQR 29.3–73.7) | < 0.001 |
Post-analytical TAT | |||
From result notification to CP discontinuation (h)a,b | 24.0 (IQR 5.7–32.8) | 17.4 (IQR 9.1–30.5) | 0.56 |
Total TAT | |||
From admission to CP discontinuation (h) | 43.4 (IQR 27.0–92.0) | 67.4 (IQR 34.7–84.6) | 0.29 |
From admission to result notification (h)a | 22.1 (IQR 12.3–55.2) | 61.9 (IQR 56.7–105.0) | < 0.001 |